|
Apr 22
|
Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
|
|
Apr 18
|
US FDA mandates label updates on CAR-T cancer therapies
|
|
Apr 18
|
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Apr 18
|
Gilead Sciences Publishes 2023 ESG Impact Report
|
|
Apr 18
|
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 17
|
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
|
|
Apr 16
|
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
|
|
Apr 16
|
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
|
|
Apr 15
|
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
|
|
Apr 15
|
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA
|
|
Apr 15
|
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG
|
|
Apr 12
|
Gilead Sciences (GILD) Stock Moves -0.84%: What You Should Know
|
|
Apr 10
|
12 Best Depressed Stocks To Buy in 2024
|
|
Apr 9
|
Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider
|
|
Apr 9
|
3 Stocks at 52-Week Lows Poised for a Powerful Rebound
|
|
Apr 9
|
11 Best Biotech ETFs To Buy
|
|
Apr 8
|
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
|
|
Apr 6
|
3 No-Brainer Dividend Stocks to Buy in April
|
|
Apr 5
|
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
|
|
Apr 3
|
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
|